Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Amyotrophic lateral sclerosis (ALS) is a degenerative disorder of motor neurons in the cortex, brainstem and spinal cord. Its cause is unknown and it is uniformly fatal, typically within five years. About 10% of cases are inherited as an autosomal dominant trait, with high penetrance after the sixth decade. In most instances, sporadic and autosomal dominant familial ALS (FALS) are clinically similar. We have previously shown that in some but not all FALS pedigrees the disease is linked to a genetic defect on chromosome 21q (refs 8, 9). Here we report tight genetic linkage between FALS and a gene that encodes a cytosolic, Cu/Zn-binding superoxide dismutase (SOD1), a homodimeric metalloenzyme that catalyzes the dismutation of the toxic superoxide anion O2.- to O2 and H2O2 (ref. 10). Given this linkage and the potential role of free radical toxicity in other neurodenegerative disorders, we investigated SOD1 as a candidate gene in FALS. We identified 11 different SOD1 missense mutations in 13 different FALS families.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Long-standing associations of some forms of ALS with mutations in genes coding for superoxide dismutase 1”
Citations
Cites
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Orita, M., Suzuki, Y., Sekiya, T., & Hayashi, K. (1989) · Genomics · doi:10.1016/0888-7543(89)90129-8 · Cited by 3,434
DNA damage and oxygen radical toxicity
Imlay, J. A., & Linn, S. (1988) · Science · doi:10.1126/science.3287616 · Cited by 1,974
Analysis of Human Genetic Linkage.
Edwards, A. W. F., & Ott, J. (1992) · Biometrics · doi:10.2307/2532370 · Cited by 1,691
Functional inactivation of genes by dominant negative mutations
Herskowitz, I. (1987) · Nature · doi:10.1038/329219a0 · Cited by 1,160
Carlioz, A., & Touati, D. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04256.x · Cited by 784
Centre d'Etude du polymorphisme humain (CEPH): Collaborative genetic mapping of the human genome
Dausset, J., Cann, H., Cohen, D., Lathrop, M., Lalouel, J.-M., & White, R. (1990) · Genomics · doi:10.1016/0888-7543(90)90491-c · Cited by 575
Copper,zinc superoxide dismutase is primarily a cytosolic protein in human cells.
Crapo, J. D., Oury, T., Rabouille, C., Slot, J. W., & Chang, L. Y. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10405 · Cited by 503
Richardson, J., Thomas, K. A., Rubin, B. H., & Richardson, D. C. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.4.1349 · Cited by 403
Familial adult motor neuron disease: amyotrophic lateralsclerosis
(1986) · Neurology · doi:10.1212/wnl.36.4.511 · Cited by 401
Self-citation
Research works printed but not linked: 7
- Kurland, L. T. Proc. Staff Meet Mayo Clin. 32, 449–462 (1957).
- Swerts, L. & Van Den Bergh, R. J. J. genet. Hum. 24, 247–255 (1976).
- Fridovich, I. Adv. Enzym. 58, 61–97 (1986).
- Ott, J. Am. hum. Genet. 28, 528–529 (1976).
- Ott, J. Analysis of Human Genetics 203–216 (Johns Hopkins Univ. Press, Baltimore, 1991).
- Hallewell, R. A. et al. in Superoxide Dismutase in Chemistry, Biology and Medicine (ed. Rotilio, G.) 249–256 (Elsevier, 1986).
- Muller, H. in Sixth internat. Congr. Genetics (ed. Jones, D.) 213–255 (Brooklyn Botanic Gardens, Menasha, 1932).
Cited by
Items 901–1,000 of 1,128
Adipose-derived stem cell exosomes alleviate pathology of amyotrophic lateral sclerosis in vitro
Lee, M., Ban, J.-J., Kim, K.-Y., Jeon, G. S., Im, W., Sung, J., & Kim, M. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.069 · Cited by 161
Syková, E., Rychmach, P., Drahorádová, I., Konrádová, Š., Růžičková, K., Voříšek, I., Forostyak, S., Homola, A., & Bojar, M. (2017) · Cell Transplantation · doi:10.3727/096368916x693716 · Cited by 156
ALSOD: The Amyotrophic Lateral Sclerosis Online Database
Wroe, R., Wai-Ling Butler, A., Andersen, P. M., Powell, J. F., & Al-Chalabi, A. (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802146106 · Cited by 158
“In 12 23% of those with a family history and about 2 7% of all cases, mutations are found in the SOD1 gene (1).”
BackgroundMitochondrial Dysfunction in Neurodegenerative Diseases Associated with Copper Imbalance
Rossi, L. C., Lombardo, M. F., Ciriolo, M. R., & Rotilio, G. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000014820.99232.8a · Cited by 174
Metal Ion Physiopathology in Neurodegenerative Disorders
Bolognin, S., Messori, L., & Zatta, P. F. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8102-1 · Cited by 169
Modeling neurodegeneration in Caenorhabditis elegans
Caldwell, K. A., Willicott, C. W., & Caldwell, G. A. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.046110 · Cited by 178
Copper deficiency and neurological disorders in man and animals
Zatta, P. F., & Frank, A. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.10.001 · Cited by 170
Amyotrophic Lateral Sclerosis: From Current Developments in the Laboratory to Clinical Implications
Cozzolino, M., Ferri, A., & Teresa Carrì, M. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1760 · Cited by 156
Rodent models of amyotrophic lateral sclerosis
McGoldrick, P., Joyce, P. I., Fisher, E., & Greensmith, L. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.012 · Cited by 189
Soon, C. P. W., Donnelly, P. S., Turner, B. J., Hung, L. W., Crouch, P. J., Sherratt, N. A., Tan, J., Lim, N. K.-H., Lam, L. Q., Bica, L., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.274407 · Cited by 166
Redox Control of the Survival of Healthy and Diseased Cells
Zhang, Y., Du, Y., Le, W., Wang, K., Kieffer, N., & Zhang, J. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3685 · Cited by 153
“The direct evidence for the participation of overloaded ROS is that the antioxidant enzyme SOD1 is mutated in cases of familial amyotrophic lateral sclerosis (FALS) (313).”
Astrocytes and Microglia as Non-cell Autonomous Players in the Pathogenesis of ALS
Lee, J., Hyeon, S. J., Im, H., Ryu, H., Kim, Y., & Ryu, H. (2016) · Experimental Neurobiology · doi:10.5607/en.2016.25.5.233 · Cited by 155
“In FALS, more than 90 mutations are found in superoxide dismutase 1 (SOD1) gene [3-6].”
BackgroundHuang, M., Chiang, S., Kalinowski, D. S., Bae, D.-H., Sahni, S., & Richardson, D. R. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6392763 · Cited by 169
“Approximately 10% of ALS are familial cases, of which about 20% are due to autosomal dominant mutations in Cu/Zn-superoxide dismutase (SOD1), which is a major antioxidant enzyme [205].”
BackgroundDisruption of Glial Glutamate Transport by Reactive Oxygen Species Produced in Motor Neurons
Rao, S. D., Yin, H. Z., & Weiss, J. H. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02627.2003 · Cited by 155
“However, to begin to address the degree to which similar events might occur in vivo, we made use of transgenic mice expressing the G93A mutant form of SOD1, associated with familial forms of ALS (Gurney et al., 1994).”
BackgroundInfluentialVascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS
Zheng, C., Nennesmo, I., Fadeel, B., & Henter, J. (2004) · Annals of Neurology · doi:10.1002/ana.20223 · Cited by 156
Radunovic, A., & Leigh, P. N. (1996) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.61.6.565 · Cited by 155
Ince, P. G., Highley, J. R., Kirby, J., Wharton, S. B., Takahashi, H., Strong, M. J., & Shaw, P. J. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0913-0 · Cited by 171
“[123]”
In Vitro Microfluidic Models for Neurodegenerative Disorders
Osaki, T., Shin, Y., Sivathanu, V., Campisi, M., & Kamm, R. D. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700489 · Cited by 154
Mattson, M. P. (1994) · PubMed · Cited by 154
Kuo, J. J., Lee, R. H., Zhang, L., & Heckman, C. J. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.107094 · Cited by 152
“Animals with the mutant version of the SOD1 gene are a standard model of amyotrophic lateral sclerosis (Rosen et al. 1993) and we have previously shown that cells from these animals have significantly larger amplitudes for NaP than cells from animals with wild-type SOD1 genes or from control animals (Kuo et al.”
BackgroundOxidative Stress in Airways: Is There a Role for Extracellular Superoxide Dismutase?
Bowler, R. P., & Crapo, J. D. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2206014 · Cited by 154
Fisher, K. M., Zaaimi, B., Williams, T. L., Baker, S. N., & Baker, M. R. (2012) · Brain · doi:10.1093/brain/aws150 · Cited by 168
“This mutation has been shown to be linked to familial amyotrophic lateral sclerosis (Rosen et al., 1993).”
BackgroundChandrasekaran, A., Avci, H. X., Leist, M., Kobolák, J., & Dinnyés, A. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00215 · Cited by 153
“…gliotransmission is supported by findings that dysfunction of astrocytic proteins involved in transmitter release can cause severe brain disorders (Rossi et al., 2011), there are still several features of gliotransmission that are controversial and require further clarification (Hamilton and…”
BackgroundThe molecular and cellular basis of copper dysregulation and its relationship with human pathologies
Maung, M. T., Carlson, A., Olea‐Flores, M., Elkhadragy, L., Schachtschneider, K. M., Navarro‐Tito, N., & Padilla‐Benavides, T. (2021) · The FASEB Journal · doi:10.1096/fj.202100273rr · Cited by 173
Folz, R. J., Guan, J., Seldin, M. F., Oury, T. D., Enghild, J. J., & Crapo, J. D. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.17.4.2826 · Cited by 153
Axonal Degeneration in Motor Neuron Disease
Fischer, L. R., & Glass, J. D. (2007) · Neurodegenerative Diseases · doi:10.1159/000107704 · Cited by 152
The Role of Oxidative Stress in Chronic Obstructive Pulmonary Disease
Bowler, R. P., Barnes, P. J., & Crapo, J. D. (2004) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1081/copd-200027031 · Cited by 166
Chou, S. M., Wang, H. S., & Komai, K. (1996) · Journal of Chemical Neuroanatomy · doi:10.1016/0891-0618(96)00137-8 · Cited by 173
Protein precipitation: a common etiology in neurodegenerative disorders?
Kakizuka, A. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01559-5 · Cited by 163
Wong, P. C., Marszalek, J., Crawford, T. O., Xu, Z., Hsieh, S. T., Griffin, J. W., & Cleveland, D. W. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.6.1413 · Cited by 132
“This has been proven unequivocally to be true in a mutant Japanese quail, in which premature translation termination of NF-L blocks filament assembly (Ohara et al., 1993), and the resultant axons fail to grow radially (Sakaguchi et al., 1993).”
BackgroundKabashi, E., Agar, J. N., Taylor, D. M., Minotti, S., & Durham, H. D. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02453.x · Cited by 153
De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis
DeJesus-Hernandez, M., Kocerha, J., Finch, N., Crook, R., Baker, M., Desaro, P., Johnston, A., Rutherford, N., Wojtas, A., Kennelly, K., et al. (2010) · Human Mutation · doi:10.1002/humu.21241 · Cited by 151
Intricate interplay between astrocytes and motor neurons in ALS
Phatnani, H. P., Guarnieri, P., Friedman, B. A., Carrasco, M. A., Muratet, M., O’Keeffe, S., Nwakeze, C., Pauli-Behn, F., Newberry, K. M., Meadows, S. K., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222361110 · Cited by 152
“2), among which ∼20–25% are caused by dominantly inherited mutations in the SOD1 gene; this gene encodes a cytosolic Cu/Zn superoxide dismutase (3).”
BackgroundSystemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis
Freischmidt, A., Müller, K., Ludolph, A. C., & Weishaupt, J. H. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-42 · Cited by 152
Ding, F., & Dokholyan, N. V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803266105 · Cited by 166
“A large set of mutations in this ubiquitous cytosolic enzyme has been identified in familial ALS diseases (1, 2).”
BackgroundAntibody Aggregation: Insights from Sequence and Structure
Li, W., Prabakaran, P., Chen, W., Zhu, Z., Feng, Y., & Dimitrov, D. (2016) · Antibodies · doi:10.3390/antib5030019 · Cited by 149
“For example, many proteins involved in hereditary forms of protein deposition diseases bear mutations decreasing the conformational stability of the folded monomer and promote aggregation in vitro [38,41,42].”
BackgroundKim, K., Moore, D. H., Makriyannis, A., & Abood, M. E. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.05.025 · Cited by 164
Structural Characterization of Zinc-deficient Human Superoxide Dismutase and Implications for ALS
Roberts, B. R., Tainer, J. A., Getzoff, E. D., Malencik, D. A., Anderson, S. R., Bomben, V. C., Meyers, K. R., Karplus, P. A., & Beckman, J. S. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.07.043 · Cited by 163
“Aggregation of the protein was measure using two methods: (1) the difference in absorbance between baseline and after the sample had reached equilibrium (2) after the completion of the equilibrium run the samples were agitated and then the baseline absorbance was taken and compared to the initial baseline measurement.”
MethodProtein quality control in Alzheimer's disease by the ubiquitin proteasome system
de Vrij, F. M. S., Fischer, D. F., VANLEEUWEN, F., & Hol, E. M. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.10.001 · Cited by 172
Oxidative damage in age-related macular degeneration.
Shen, J., Dong, A., Hackett, S. F., Bell, W. R., Green, W. R., & Campochiaro, P. A. (2007) · PubMed · doi:10.14670/hh-22.1301 · Cited by 150
Borchelt, D. R., Guarnieri, M., Wong, P. C., Lee, M. K., Slunt, H. S., Xu, Z.-S., Sisodia, S. S., Price, D. L., & Cleveland, D. W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.3234 · Cited by 151
Common variants of the vitamin D binding protein gene and adverse health outcomes
Malik, S., Fu, L., Juras, D. J., Karmali, M., Wong, B. Y. L., Gozdzik, A., & Cole, D. E. C. (2013) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2012.750262 · Cited by 151
Bendotti, C., Marino, M., Cheroni, C., Fontana, E., Crippa, V., Poletti, A., & Biasi, S. D. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.10.001 · Cited by 187
Protein aggregation can inhibit clathrin-mediated endocytosis by chaperone competition
Yu, A., Shibata, Y., Shah, B., Calamini, B., Lo, D. C., & Morimoto, R. I. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321811111 · Cited by 151
“In addition, mutant superoxide dismutase-1 (SOD1) A4V, associated with familial ALS, was tested (35).”
BackgroundPrause, J., Goswami, A., Katona, I., Roos, A., Schnizler, M., Bushuven, E., Dreier, A., Buchkremer, S., Johann, S., Beyer, C., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt008 · Cited by 151
“Mutations causing fALS account for 5–10% of all ALS cases and share pathological features with sALS cases (9,10).”
BackgroundFrom animal models to human disease: a genetic approach for personalized medicine in ALS
Picher-Martel, V., Valdmanis, P. N., Gould, P. V., Julien, J.-P., & Dupré, N. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0340-5 · Cited by 151
“Specific disease characteristics in humans Mutations in the SOD1 gene have been the first described cause of familial ALS [43].”
BackgroundHayes, J. D., & Pulford, D. J. (1995) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239509083492 · Cited by 469
Shibata, N., Hirano, A., Kobayashi, M., Sasaki, S., Kato, T., Matsumoto, S., Shiozawa, Z., Komori, T., Ikemoto, A., Umahara, T., et al. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90956-3 · Cited by 151
Marzia Perluigi, A., Poon, H. F., Hensley, K., Pierce, W. M. J., Klein, J. B., Calabrese, V., Marco, C. M. D., & Butterfield, D. A. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.12.021 · Cited by 155
“fALS is caused by dominantly inherited mutations in the SOD1 gene encoding Cu/Zn superoxide dismutase [2].”
BackgroundOverexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafish
Lemmens, R., Van Hoecke, A., Hersmus, N., Geelen, V., D'Hollander, I., Thijs, V., Van Den Bosch, L., Carmeliet, P., & Robberecht, W. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm193 · Cited by 151
“In one out of five of such families, mutations in the superoxide dismutase 1 (SOD1) gene underlie the disease (2).”
Furuta, A., Price, D. L., Pardo, C. A., Troncoso, J. C., Xu, Z., Taniguchi, N., & Martin, L. J. (1995) · Europe PMC (PubMed Central) · Cited by 167
The Genetics of Axonal Transport and Axonal Transport Disorders
Duncan, J. E., & Goldstein, L. S. B. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020124 · Cited by 150
“D O I: 1 0 .1 3 7 1 /j o u rn al .p g e n .0 0 2 0 1 2 4 .t 0 0 3 PLoS Genetics | www.plosgenetics.org September 2006 | Volume 2 | Issue 9 | e1241281 to each disease are transported in the axon and can perturb transport when manipulated; presenilin 1 and APP in AD, Cu/ Zn superoxide dismutase (SOD1) in ALS, and huntin…”
BackgroundInfluentialGowing, G., Philips, T., Van Wijmeersch, B., Audet, J.-N., Dewil, M., Van Den Bosch, L., Billiau, A. D., Robberecht, W., & Julien, J.-P. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3494-08.2008 · Cited by 148
Exome sequencing to identify de novo mutations in sporadic ALS trios
Chesi, A., Staahl, B. T., Jovičić, A., Couthouis, J., Fasolino, M., Raphael, A. R., Yamazaki, T., Elias, L., Polak, M., Kelly, C., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3412 · Cited by 150
Role of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute Neuropathologies
Carvajal, F. J., Mattison, H. A., & Cerpa, W. (2016) · Neural Plasticity · doi:10.1155/2016/2701526 · Cited by 148
Prion-Like Propagation of Protein Misfolding and Aggregation in Amyotrophic Lateral Sclerosis
McAlary, L., Plotkin, S. S., Yerbury, J. J., & Cashman, N. R. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00262 · Cited by 171
“SOD1 Structure and Function Superoxide dismutase-1 (SOD1) was the first gene linked to familial ALS (Rosen et al., 1993), and since this initial discovery, there have been over 160 fALS-associated mutations identified in the Sod1 gene (Abel et al.”
BackgroundInfluentialMitochondria in Amyotrophic Lateral Sclerosis: A Trigger and a Target
Dupuis, L., Gonzalez de Aguilar, J.-L., Oudart, H., de Tapia, M., Barbeito, L., & Loeffler, J.-P. (2004) · Neurodegenerative Diseases · doi:10.1159/000085063 · Cited by 149
Xie, Y., Zhou, B., Lin, M.-Y., Wang, S., Foust, K. D., & Sheng, Z.-H. (2015) · Neuron · doi:10.1016/j.neuron.2015.06.026 · Cited by 149
“About 10% of ALS cases are familial, of which over 20% are associated with dominant mutations in Cu/Zn superoxide dismutase (SOD1) genes (Rosen et al., 1993).”
BackgroundJiang, Z., Hu, Z., Zeng, L., Lu, W., Zhang, H., Li, T., & Xiao, H. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.01.011 · Cited by 163
Ayers, J. I., Fromholt, S. E., O’Neal, V. M., Diamond, J. H., & Borchelt, D. R. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1514-0 · Cited by 149
“Approximately 10 % of all ALS cases have a familial etiology (fALS), and mutations in superoxide dismutase-1 (SOD1) were the first to be identified as causative [22].”
BackgroundInvited Review: The role of prion‐like mechanisms in neurodegenerative diseases
Jaunmuktane, Z., & Brandner, S. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12592 · Cited by 150
Reactive Oxygen Species: Beyond Their Reactive Behavior
Tauffenberger, A., & Magistretti, P. J. (2021) · Neurochemical Research · doi:10.1007/s11064-020-03208-7 · Cited by 172
Genistein Is Neuroprotective in Murine Models of Familial Amyotrophic Lateral Sclerosis and Stroke
Trieu, V. N., & Uckun, F. M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0577 · Cited by 149
Direct Detection of 8-Oxodeoxyguanosine and 8-Oxoguanine by Avidin and Its Analogues
Struthers, L., Patel, R., Clark, J., & Thomas, S. M. (1998) · Analytical Biochemistry · doi:10.1006/abio.1997.2354 · Cited by 150
Dangond, F., Hwang, D., Camelo, S., Pasinelli, P., Frosch, M. P., Stephanopoulos, G., Stephanopoulos, G., Brown, R. H., & Gullans, S. R. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00087.2001 · Cited by 149
“Of the two familial specimens, one was from an individual with a superoxide dismutase 1 mutation (SOD1- A4V); the gene defect in the other was not defined (samples were not tested for the recently described Alsin mutations since the phenotype did not correspond to that described for familial juvenile ALS).”
BackgroundInfluentialSelf-citation10 Years ofGenomics,Chromosome 21, and Down Syndrome
Antonarakis, S. E. (1998) · Genomics · doi:10.1006/geno.1998.5335 · Cited by 148
Yim, H.-S., Kang, J.-H., Chock, P. B., Stadtman, E. R., & Yim, M. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.8861 · Cited by 149
The rationale for the use of dopamine agonists in Parkinson's disease
Jenner, P. (1995) · Neurology · doi:10.1212/wnl.45.3_suppl_3.s6 · Cited by 149
RNA oxidation in Alzheimer disease and related neurodegenerative disorders
Nunomura, A., Hofer, T., Moreira, P. I., Castellani, R. J., Smith, M. A., & Perry, G. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0508-1 · Cited by 148
“A strong genetic link between oxidative damage and neurodegeneration has been suggested by the finding that in about 20% of patients with familial ALS, it is caused by a mutation in SOD1, a metalloenzyme that catalyzes the dismutation of the toxic superoxide (O2 ) to hydrogen peroxide (H2O2) [98].”
BackgroundSOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS
Hayashi, Y., Homma, K., & Ichijo, H. (2015) · Advances in Biological Regulation · doi:10.1016/j.jbior.2015.10.006 · Cited by 177
“In 1993, the identification of the SOD1 gene encoding Cu,Zn superoxide dismutase as a primary cause of ALS accelerated ALS research (Rosen et al., 1993).”
BackgroundOxidative Modification to Cysteine Sulfonic Acid of Cys111 in Human Copper-Zinc Superoxide Dismutase
Fujiwara, N., Nakano, M., Kato, S., Yoshihara, D., Ookawara, T., Eguchi, H., Taniguchi, N., & Suzuki, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702941200 · Cited by 147
Poon, H. F., Hensley, K., Thongboonkerd, V., Merchant, M. L., Lynn, B. C., Pierce, W. M. J., Klein, J. B., Calabrese, V., & Butterfield, D. A. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.03.030 · Cited by 161
“Inherited ALS accounts for 10– 15% of cases, and among all of the familial ALS (FALS) patients, 20–30% of them are caused by a gain-of-function mutation in Cu,Zn-superoxide dismutase (SOD1) [3,4].”
BackgroundMarangi, G., & Traynor, B. J. (2015) · Brain Research · doi:10.1016/j.brainres.2014.10.009 · Cited by 148
Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients
Lee, T., Li, Y. R., Ingre, C., Weber, M., Grehl, T., Gredal, O., de Carvalho, M., Meyer, T., Tysnes, O.-B., Auburger, G., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr045 · Cited by 148
“The first gene associated with FALS was SOD1, which encodes superoxide dismutase 1 (1).”
BackgroundBota, D. A., & Davies, K. J. A. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.06.031 · Cited by 164
“Mutations in copper-zinc superoxide dismutase (SOD1) represent the most common defect seen in the familial forms of ALS (fALS) [73].”
Autophagy Dysregulation in ALS: When Protein Aggregates Get Out of Hand
Ramesh, N., & Pandey, U. B. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00263 · Cited by 148
“In 1993, the first genetic mutations were identified in the SOD1 gene in individuals with fALS (Rosen et al., 1993) Further studies of fALS genomes has led to the discovery of more than 100 mutations in the SOD1 gene.”
BackgroundThe syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis
Strong, M. J. (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802372371 · Cited by 148
IGF-I prevents glutamate-induced motor neuron programmed cell death
Vincent, A. M., Mobley, B. C., Hiller, A., & Feldman, E. L. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.03.001 · Cited by 147
Mohajeri, M. H., Figlewicz, D. A., & Bohn, M. C. (1999) · Human Gene Therapy · doi:10.1089/10430349950017536 · Cited by 148
Self-citationTalbot, K. (2002) · Postgraduate Medical Journal · doi:10.1136/pmj.78.923.513 · Cited by 147
Mutations in all five exons of SOD‐1 may cause ALS
Shaw, C. E., Enayat, Z. E., Chioza, B. A., Al‐Chalabi, A., Radunovic, A., Powell, J. F., & Leigh, P. N. (1998) · Annals of Neurology · doi:10.1002/ana.410430319 · Cited by 147
SOD1, an unexpected novel target for cancer therapy.
Papa, L., Manfredi, G., & Germain, D. (2014) · Genes & Cancer · doi:10.18632/genesandcancer.4 · Cited by 147
Crugnola, V., Lamperti, C., Lucchini, V., Ronchi, D., Peverelli, L., Prelle, A., Sciacco, M., Bordoni, A., Fassone, E., Fortunato, F., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.128 · Cited by 146
“As a rule, the disease progresses rapidly and causes widespread paralysis and spasticity.(1,2) The prevalence of ALS is approximately 1 to 2 in 100 000 individuals.”
BackgroundMolecular and Cellular Mechanisms Affected in ALS
Le Gall, L., Anakor, E., Connolly, O., Vijayakumar, U., Duddy, W., & Duguez, S. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030101 · Cited by 145
Non-neuronal cells in amyotrophic lateral sclerosis — from pathogenesis to biomarkers
Vahsen, B. F., Gray, E., Thompson, A. G., Ansorge, O., Anthony, D. C., Cowley, S. A., Talbot, K., & Turner, M. R. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00487-8 · Cited by 147
Metabolomic analysis and signatures in motor neuron disease
Rozen, S., Cudkowicz, M., Bogdanov, M. B., Matson, W. R., Kristal, B. S., Beecher, C., Harrison, S. J., Vouros, P., Flarakos, J., Vigneau-Callahan, K. E., et al. (2005) · Metabolomics · doi:10.1007/s11306-005-4810-1 · Cited by 164
“Four subjects had familial ALS (FALS), one of whom had an SOD1 mutation.”
BackgroundSelf-citationGenetic epidemiology of amyotrophic lateral sclerosis
Majoor‐Krakauer, D., Willems, P., & Hofman, A. (2003) · Clinical Genetics · doi:10.1046/j.0009-9163.2002.00001.x · Cited by 147
“Two years later the cytosolic copper-zinc superoxide dismutase (SOD1) gene was shown to be the ALS1 gene (73).”
BackgroundBlood-CNS Barrier Impairment in ALS patients versus an animal model
Garbuzova-Davis, S., & Sanberg, P. R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00021 · Cited by 146
“REVIEW ARTICLE published: 03 February 2014 doi: 10.3389/fncel.2014.00021 Blood–CNS barrier impairment in ALS patients versus an animal model”
BackgroundInfluentialSong, S., Miranda, C. J., Braun, L., Meyer, K., Frakes, A. E., Ferraiuolo, L., Likhite, S., Bevan, A. K., Foust, K. D., McConnell, M. J., et al. (2016) · Nature Medicine · doi:10.1038/nm.4052 · Cited by 145
Antioxidant and Prooxidant Nanozymes: From Cellular Redox Regulation to Next‐Generation Therapeutics
Singh, N., Sherin, G. R., & Mugesh, G. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202301232 · Cited by 167
Hyun, D., Lee, M., Halliwell, B., & Jenner, P. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01841.x · Cited by 146
Programmed cell death in amyotrophic lateral sclerosis
Guégan, C., & Przedborski, S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17610 · Cited by 145
Redox modifier genes in amyotrophic lateral sclerosis in mice
Marden, J. J., Harraz, M. M., Williams, A. J., Nelson, K., Luo, M., Paulson, H., & Engelhardt, J. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31265 · Cited by 145
Flightless flies: Drosophila models of neuromuscular disease
Lloyd, T. E., & Taylor, J. P. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05432.x · Cited by 200
Wang, H., O'Reilly, E. J., Weisskopf, M. G., Logroscino, G., McCullough, M. L., Schatzkin, A., Kolonel, L. N., & Ascherio, A. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwq416 · Cited by 145
Protecting Motor Neurons from Toxic Insult by Antagonism of Adenosine A2a and Trk Receptors
Mojsilovic-Petrovic, J., Jeong, G.-B., Crocker, A., Arneja, A., David, S., Russell, D., & Kalb, R. G. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1856-06.2006 · Cited by 143
Furukawa, Y., & O’Halloran, T. V. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.847 · Cited by 172
Cyclin‐dependent kinase‐5 in neurodegeneration
Shelton, S. B., & Johnson, G. V. W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2003.02328.x · Cited by 145
Involvement of CHOP, an ER-stress apoptotic mediator, in both human sporadic ALS and ALS model mice
Ito, Y., Yamada, M., Tanaka, H., Aida, K., Tsuruma, K., Shimazawa, M., Hozumi, I., Inuzuka, T., Takahashi, H., & Hara, H. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.08.013 · Cited by 141
ALS and other motor neuron diseases
Tiryaki, E., & Horak, H. A. (2014) · Continuum · doi:10.1212/01.con.0000455886.14298.a4 · Cited by 143
“This review describes the most common motor neuron disease, ALS.”
BackgroundInfluential
Metadata
- Authors
- Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., Rahmani, Z., Krizus, A., McKenna-Yasek, D., Cayabyab, A., Gaston, S. M., Berger, R., Tanzi, R. E., Halperin, J. J., Herzfeldt, B., Van den Bergh, R., Hung, W.-Y., Bird, T., Deng, G., Mulder, D. W., Smyth, C., Laing, N. G., Soriano, E., Pericak–Vance, M. A., Haines, J., Rouleau, G. A., Gusella, J. S., Horvitz, H. R., & Brown, R. H.
- Affiliations
- Massachusetts General Hospital (US)
- Northwestern University (US)
- Montreal General Hospital (CA)
- Howard Hughes Medical Institute (US)
- North Shore University Hospital (US)
- University of Washington (US)
- Mayo Clinic (US)
- ORCID
- Venue
- Nature
- Published
- 1993-03-01
- Volume
- 362
- Issue
- 6415
- Pages
- 59-62
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2096386031
- Cited by
- 7,062
- References
- 42
- Citations by year
- 2026: 137 · 2025: 154 · 2024: 201 · 2023: 185 · 2022: 254 · 2021: 259 · 2020: 295 · 2019: 205 · 2018: 258 · 2017: 248 · 2016: 242 · 2015: 248 · 2014: 262 · 2013: 264 · 2012: 315
- FWCI
- 174.77
- Type
- journal article
- Language
- en
- Update notices
- correction (1993-07-22)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- amyotrophic lateral sclerosis, familial ALS, SOD1, Cu/Zn superoxide dismutase, missense mutations, genetic linkage, chromosome 21q, autosomal dominant inheritance, free radical toxicity, candidate genes, motor neuron degeneration
- MeSH terms
- Amino Acid Sequence, Amyotrophic Lateral Sclerosis, Animals, Base Sequence, Codon, DNA, Exons, Humans, Isoenzymes, Lod Score, Molecular Sequence Data, Mutation, Nucleic Acid Conformation, Oligodeoxyribonucleotides, Polymorphism, Genetic, Repetitive Sequences, Nucleic Acid, Superoxide Dismutase, Genome, Human, Polymerase Chain Reaction, Sequence Homology, Amino Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.